BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 32340804)

  • 1. Intermediate-term outcomes of aortic valve replacement using a bioprosthesis with a novel tissue.
    Johnston DR; Griffith BP; Puskas JD; Bavaria JE; Svensson LG;
    J Thorac Cardiovasc Surg; 2021 Nov; 162(5):1478-1485. PubMed ID: 32340804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety, efficacy, and hemodynamic performance of a stented bovine pericardial aortic valve bioprosthesis: Two-year analysis.
    Dagenais F; Moront MG; Brown WM; Reardon MJ; Chu MWA; Gearhart E; Klautz RJM
    J Thorac Cardiovasc Surg; 2020 Aug; 160(2):371-381.e4. PubMed ID: 31590957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-year Outcomes of the COMMENCE Trial Investigating Aortic Valve Replacement With RESILIA Tissue.
    Bavaria JE; Griffith B; Heimansohn DA; Rozanski J; Johnston DR; Bartus K; Girardi LN; Beaver T; Takayama H; Mumtaz MA; Rosengart TK; Starnes V; Timek TA; Boateng P; Ryan W; Cornwell LD; Blackstone EH; Borger MA; Pibarot P; Thourani VH; Svensson LG; Puskas JD;
    Ann Thorac Surg; 2023 Jun; 115(6):1429-1436. PubMed ID: 35065065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The COMMENCE trial: 2-year outcomes with an aortic bioprosthesis with RESILIA tissue.
    Puskas JD; Bavaria JE; Svensson LG; Blackstone EH; Griffith B; Gammie JS; Heimansohn DA; Sadowski J; Bartus K; Johnston DR; Rozanski J; Rosengart T; Girardi LN; Klodell CT; Mumtaz MA; Takayama H; Halkos M; Starnes V; Boateng P; Timek TA; Ryan W; Omer S; Smith CR;
    Eur J Cardiothorac Surg; 2017 Sep; 52(3):432-439. PubMed ID: 28605428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective US investigational device exemption trial of a sutureless aortic bioprosthesis: One-year outcomes.
    Suri RM; Javadikasgari H; Heimansohn DA; Weissman NJ; Ailawadi G; Ad N; Aldea GS; Thourani VH; Szeto WY; Michler RE; Michelena HI; Dabir R; Fontana GP; Kessler WF; Moront MG; Brunsting LA; Griffith BP; Montoya A; Subramanian S; Mostovych MA; Roselli EE
    J Thorac Cardiovasc Surg; 2019 May; 157(5):1773-1782.e3. PubMed ID: 30553598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The St Jude Medical Trifecta aortic pericardial valve: results from a global, multicenter, prospective clinical study.
    Bavaria JE; Desai ND; Cheung A; Petracek MR; Groh MA; Borger MA; Schaff HV
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):590-7. PubMed ID: 23477687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ten-year comparison of pericardial tissue valves versus mechanical prostheses for aortic valve replacement in patients younger than 60 years of age.
    Weber A; Noureddine H; Englberger L; Dick F; Gahl B; Aymard T; Czerny M; Tevaearai H; Stalder M; Carrel TP
    J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1075-83. PubMed ID: 22341653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-year outcomes of the Surgical Treatment of Aortic Stenosis With a Next Generation Surgical Aortic Valve (TRITON) trial: a prospective multicenter study of rapid-deployment aortic valve replacement with the EDWARDS INTUITY Valve System.
    Kocher AA; Laufer G; Haverich A; Shrestha M; Walther T; Misfeld M; Kempfert J; Gillam L; Schmitz C; Wahlers TC; Wippermann J; Mohr FW; Roth M; Skwara A; Rahmanian P; Wiedemann D; Borger MA
    J Thorac Cardiovasc Surg; 2013 Jan; 145(1):110-5; discussion 115-6. PubMed ID: 23058665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Outcomes of the Mosaic Aortic Porcine Bioprosthesis in Japan - Results From the Japan Mosaic Valve Long-Term Multicenter Study.
    Yoshikawa Y; Okada Y; Okita Y; Yaku H; Kobayashi J; Uesugi H; Takanashi S; Ito T; Nakao T; Koyama T; Sakaguchi T; Yamamoto K; Sawa Y
    Circ J; 2020 Jul; 84(8):1261-1270. PubMed ID: 32554951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-Year Outcomes After Bicuspid Aortic Valve Replacement With a Novel Tissue Bioprosthesis.
    Bavaria JE; Mumtaz MA; Griffith B; Svensson LG; Pibarot P; Borger MA; Thourani VH; Blackstone EH; Puskas JD
    Ann Thorac Surg; 2024 Jul; 118(1):173-179. PubMed ID: 38135262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mid-term follow up of a novel bioprosthesis in aortic valve surgery.
    Doss M; Sirat S; Kiessling AH; Jaenicke S; Moritz A
    J Heart Valve Dis; 2012 Nov; 21(6):753-7. PubMed ID: 23409357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcatheter Aortic and Mitral Valve-in-Valve Implantation for Failed Surgical Bioprosthetic Valves: An 8-Year Single-Center Experience.
    Ye J; Cheung A; Yamashita M; Wood D; Peng D; Gao M; Thompson CR; Munt B; Moss RR; Blanke P; Leipsic J; Dvir D; Webb JG
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1735-44. PubMed ID: 26476608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Final 5-year outcomes following aortic valve replacement with a RESILIA™ tissue bioprosthesis.
    Bartus K; Litwinowicz R; Bilewska A; Stapor M; Bochenek M; Rozanski J; Sadowski J; Filip G; Kusmierczyk M; Kapelak B
    Eur J Cardiothorac Surg; 2021 Jan; 59(2):434-441. PubMed ID: 33141188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aortic valve replacement with the Cardioprotese Premium bovine pericardium bioprosthesis: four-year clinical results.
    Farias FR; da Costa FD; Balbi Filho EM; Fornazari Dde F; Collatusso C; Ferreira AD; Lopes SV; Fernandes TA
    Interact Cardiovasc Thorac Surg; 2012 Aug; 15(2):229-34. PubMed ID: 22588029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early single-center experience in sutureless aortic valve implantation in 120 patients.
    Eichstaedt HC; Easo J; Härle T; Dapunt OE
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):370-5. PubMed ID: 23473011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Midterm, multicenter clinical and hemodynamic results for the Trifecta aortic pericardial valve.
    Goldman S; Cheung A; Bavaria JE; Petracek MR; Groh MA; Schaff HV
    J Thorac Cardiovasc Surg; 2017 Mar; 153(3):561-569.e2. PubMed ID: 27964975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rate, Timing, Correlates, and Outcomes of Hemodynamic Valve Deterioration After Bioprosthetic Surgical Aortic Valve Replacement.
    Salaun E; Mahjoub H; Girerd N; Dagenais F; Voisine P; Mohammadi S; Yanagawa B; Kalavrouziotis D; Juni P; Verma S; Puri R; Coté N; Rodés-Cabau J; Mathieu P; Clavel MA; Pibarot P
    Circulation; 2018 Sep; 138(10):971-985. PubMed ID: 30354532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-year outcomes after rapid-deployment aortic valve replacement.
    Young C; Laufer G; Kocher A; Solinas M; Alamanni F; Polvani G; Podesser BK; Aramendi JI; Arribas J; Bouchot O; Livi U; Massetti M; Terp K; Giot C; Glauber M
    J Thorac Cardiovasc Surg; 2018 Feb; 155(2):575-585. PubMed ID: 29415382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The new St Jude Trifecta versus Carpentier-Edwards Perimount Magna and Magna Ease aortic bioprosthesis: is there a hemodynamic superiority?
    Wendt D; Thielmann M; Plicht B; Aßmann J; Price V; Neuhäuser M; Jakob H
    J Thorac Cardiovasc Surg; 2014 May; 147(5):1553-60. PubMed ID: 23870159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late outcomes for aortic valve replacement with the Carpentier-Edwards pericardial bioprosthesis: up to 17-year follow-up in 1,000 patients.
    McClure RS; Narayanasamy N; Wiegerinck E; Lipsitz S; Maloney A; Byrne JG; Aranki SF; Couper GS; Cohn LH
    Ann Thorac Surg; 2010 May; 89(5):1410-6. PubMed ID: 20417753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.